NASDAQ · DMIIR
Drugs Made In America Acquisition II Corp. Right
Financial Services · Asset Management
$0.05
Down-$0.00 (-8.73%)
Updated Nov 7, 2026, 6:01 PM
SID Score
3.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 10.16M
- P/E ratio
- -54.87
- Dividend yield
- 0.00%
- 52-week range
- $0.05 – $0.11
- Volume
- 10.66K
- Avg. volume
- 776.48K
Price performance · DMIIR
DMIIR price history
1M range · 14 trading sessions · Daily adjusted prices
Prices through Nov 6, 2026
DMIIR closed at $0.05 after 14 trading sessions, down 28.29% for the selected period.
- Last close
- $0.05
- Period change
- -28.29%
- Period low
- $0.05
- Period high
- $0.08
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 6, 2026 | $0.0502 | $0.0503 | $0.0502 | $0.0502 | 10.66K |
| Nov 3, 2026 | $0.055 | $0.055 | $0.0502 | $0.055 | 17.77K |
| Nov 2, 2026 | $0.055 | $0.055 | $0.055 | $0.055 | 2.67K |
| Oct 30, 2026 | $0.053 | $0.053 | $0.0522 | $0.0522 | 2.49K |
| Oct 29, 2026 | $0.053 | $0.055 | $0.0523 | $0.0526 | 23.7K |
| Oct 28, 2026 | $0.05 | $0.0599 | $0.05 | $0.053 | 374.05K |
| Oct 27, 2026 | $0.07 | $0.07 | $0.07 | $0.07 | 18.21K |
| Oct 21, 2026 | $0.0748 | $0.0748 | $0.06 | $0.07 | 87.57K |
| Oct 19, 2026 | $0.0526 | $0.075 | $0.0526 | $0.075 | 645.25 |
| Oct 16, 2026 | $0.0525 | $0.0799 | $0.0525 | $0.0799 | 930.53 |
| Oct 15, 2026 | $0.0576 | $0.08 | $0.0576 | $0.0799 | 6.32K |
| Oct 14, 2026 | $0.0614 | $0.0748 | $0.0611 | $0.068 | 13.42K |
| Oct 12, 2026 | $0.05 | $0.0965 | $0.05 | $0.0748 | 164.27K |
| Oct 9, 2026 | $0.053 | $0.07 | $0.05 | $0.07 | 1.76K |
Latest DMIIR news
The latest Smart Investors Daily articles mentioning DMIIR.
Stock researchCompany · Overview
Company
Market Activity
Research & News
DMIIR research
Overview
Company profile and research snapshot.
Company profile
Drugs Made In America Acquisition II Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. The company was incorporated in 2024 and is based in Fort Lauderdale, Florida.
Analyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
